Ethnobridging Clinical Studies
Many overseas pharmaceutical companies are reaching out to CROs in the United States in order to run their clinical studies. The reason for this is because new medicines need to be tested on certain ethnicities that are now residing in the United States to see how well they will do over the patients' respective land of origin.
There is an extreme value in conducting Ethnobridging clinical research, as it can serve to expedite the drug approval process by months, even years time. Why? Because trials of this nature allow pharmaceutical companies to test out their INDs in groups of multiple ethnic backgrounds, but more specifically, in patients that would very closely mirror the demographics of groups that are actually living in other countries. This means that they would tend to have the same lifestyle (eating, exercise, etc.) habits as people that are actually residing within a different country. One of the reasons that the United States is such a great place for ethnobridging research is because of its diverse ethnic groups, especially in some regions where groups of certain ethnic backgrounds are in high concentration, such as the Southern California area.As a pharmaceutical company, it is important when choosing a clinical research organization to carry out your clinical studies, to consider the location of said clinical research organization. The best clinical research organizations for ethno-bridging clinical studies are Southern California clinical research organizations because Southern California has one of the largest, and most ethnically diverse populations. In this region, you are likely to see enclaves and cities-within-cities that are established solely because of one or another ethnic group's presence in that area, such as Little Saigon. The Southern California region is a prime area for recruiting for ethnobridging clinical research.In terms of ethnobridging clinical studies, many clinical research organizations have been successful in recruiting for these due to the location of their facilities. Southern California has a large population of Japanese and Chinese healthy volunteers which is very beneficial for ethno-bridging studies that pharmaceutical companies from overseas such as Japan or China need conducted. Clinical research organizations have conducted many and various ethnobridging clinical studies in the Phase I and Phase II areas. With past experience, many clinical research organizations in Southern California are set up for success in ethnobridging clinical trials especially with Japanese and Chinese ethnobridging studies. In order to be able to retain regular participants from the Japanese and Chinese communities, Southern California clinical research organizations provide specialty meals that are tailored for the Japanese and Chinese people. It is beneficial to have many people who work within the clinical research organization speak fluent Japanese or fluent Chinese and attend community outreach events. Often, these contract research firms will also have 24/7, multilingual Call Centers to assist in recruitment and the dissemination of trial-specific information. In conclusion, because of the diversity and high population of Japanese and Chinese in Southern California, it is very beneficial to local and overseas pharmaceutical companies to consider a Southern California clinical research organization to conduct an ethnobridging clinical research program. Not only is this region administratively and organizationally equipped to conduct research of this kind, but it is culturally sensitive and aware, as well. One of the best things that any organization can do to instill trust in their potential patients is to demonstrate a knowledge and consideration for their specific patient populations.
Useful Links:http://wcct.com/therapeutic-areas/ethnobridging/
http://www.appliedclinicaltrialsonline.com/ethnobridging-accelerate-global-drug-development
For an in-depth, informative commentary on Ethnobridging clinical studies, consider viewing this video series:
https://www.youtube.com/watch?v=x4XJ6foVGSM
There is an extreme value in conducting Ethnobridging clinical research, as it can serve to expedite the drug approval process by months, even years time. Why? Because trials of this nature allow pharmaceutical companies to test out their INDs in groups of multiple ethnic backgrounds, but more specifically, in patients that would very closely mirror the demographics of groups that are actually living in other countries. This means that they would tend to have the same lifestyle (eating, exercise, etc.) habits as people that are actually residing within a different country. One of the reasons that the United States is such a great place for ethnobridging research is because of its diverse ethnic groups, especially in some regions where groups of certain ethnic backgrounds are in high concentration, such as the Southern California area.As a pharmaceutical company, it is important when choosing a clinical research organization to carry out your clinical studies, to consider the location of said clinical research organization. The best clinical research organizations for ethno-bridging clinical studies are Southern California clinical research organizations because Southern California has one of the largest, and most ethnically diverse populations. In this region, you are likely to see enclaves and cities-within-cities that are established solely because of one or another ethnic group's presence in that area, such as Little Saigon. The Southern California region is a prime area for recruiting for ethnobridging clinical research.In terms of ethnobridging clinical studies, many clinical research organizations have been successful in recruiting for these due to the location of their facilities. Southern California has a large population of Japanese and Chinese healthy volunteers which is very beneficial for ethno-bridging studies that pharmaceutical companies from overseas such as Japan or China need conducted. Clinical research organizations have conducted many and various ethnobridging clinical studies in the Phase I and Phase II areas. With past experience, many clinical research organizations in Southern California are set up for success in ethnobridging clinical trials especially with Japanese and Chinese ethnobridging studies. In order to be able to retain regular participants from the Japanese and Chinese communities, Southern California clinical research organizations provide specialty meals that are tailored for the Japanese and Chinese people. It is beneficial to have many people who work within the clinical research organization speak fluent Japanese or fluent Chinese and attend community outreach events. Often, these contract research firms will also have 24/7, multilingual Call Centers to assist in recruitment and the dissemination of trial-specific information. In conclusion, because of the diversity and high population of Japanese and Chinese in Southern California, it is very beneficial to local and overseas pharmaceutical companies to consider a Southern California clinical research organization to conduct an ethnobridging clinical research program. Not only is this region administratively and organizationally equipped to conduct research of this kind, but it is culturally sensitive and aware, as well. One of the best things that any organization can do to instill trust in their potential patients is to demonstrate a knowledge and consideration for their specific patient populations.
Useful Links:http://wcct.com/therapeutic-areas/ethnobridging/
http://www.appliedclinicaltrialsonline.com/ethnobridging-accelerate-global-drug-development
For an in-depth, informative commentary on Ethnobridging clinical studies, consider viewing this video series:
https://www.youtube.com/watch?v=x4XJ6foVGSM
Replies